Dr. David Hess of Augusta University will head up a Phase III international clinical trial for stroke patients using the MultiStem cell therapy to... Stem cell trial aims to provide therapy for stroke victims

Dr. David Hess of Augusta University will head up a Phase III international clinical trial for stroke patients using the MultiStem cell therapy to treat ischemic stroke.

Read the full article:
Augusta Chronicle


Sign up for our free email alerts and follow us on Facebook and on Twitter @gahealthnews.
Help us fulfill our nonprofit mission with a tax-deductible donation!

Augusta Chronicle

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *

Please leave these two fields as-is:

Help us pursue our nonprofit mission with a tax-deductible donation.

Credit Cards

EVERY LITTLE BIT HELPS
Donations Welcome

Donate Icon